SCHEMBL14101519

SCHEMBL14101519

c1cc2c3c(cccc3c1)-c1cc(-c3ccc4sc5ccc(-c6ccc7ccc8cccc9ccc6c7c89)cc5c4c3)ccc1-2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
TSHR P16473 4/20 0.38
HSD17B10 Q99714 4/20 0.38
MAPK1 P28482 3/20 0.38
HPGD P15428 3/20 0.38
CASP1 P29466 3/20 0.38
CASP7 P55210 2/20 0.38
HIF1A Q16665 2/20 0.38
TP53 P04637 1/20 0.38
L3MBTL1 Q9Y468 4/20 0.37
ATM Q13315 2/20 0.37
ERBB2 P04626 1/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAOA P21397 1/20 0.34
ACHE P22303 1/20 0.34
AHR P35869 1/20 0.34
S1PR5 Q9H228 7/20 0.33
S1PR4 O95977 6/20 0.33
CYP3A4 P08684 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101669 0.92 CYP1A2 (0.40) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101662 0.92 CYP1A2 (0.40) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101518 0.90 ALDH1A1 (0.41) ALDH1A1TSHRHSD17B10MAPK1HPGD
SCHEMBL14101659 0.90 CYP1A2 (0.39) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101428 0.90 CYP1A2 (0.41) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101474 0.89 CYP1A2 (0.38) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101453 0.89 S1PR5 (0.38) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101460 0.89 S1PR5 (0.38) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101444 0.89 CYP1A2 (0.38) ALDH1A1TSHRHSD17B10HPGDL3MBTL1
SCHEMBL14101443 0.89 CYP1A2 (0.38) ALDH1A1TSHRHSD17B10HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR ALDH1A1 70/4885TSHR 4487/4885HSD17B10 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.